Major
Moderate
Slight
None
Can't tell
Side effects
Side effects as an overall problem
Side effects as an overall problem
Severity
Evaluations
Percentage
This item is relevant to you:
Severe
3
This item is relevant to you:
Moderate
5
This item is relevant to you:
Mild
9
This item is relevant to you:
None
14
Why patients stopped taking Nevirapine (NVP)
Multiple reasons could be selected
Reason
Patients
Percentage
This item is relevant to you:
Doctor's advice
13
This item is relevant to you:
Side effects too severe
10
This item is relevant to you:
Other
5
This item is relevant to you:
Course of treatment ended
2
This item is relevant to you:
Did not seem to work
2
This item is relevant to you:
Expense
2
See
all
28 patients
who've
stopped taking Nevirapine (NVP)
Duration
Stopped taking Nevirapine (NVP)
Duration
Patients
Percentage
This item is relevant to you:
Less than 1 month
3
This item is relevant to you:
1 - 6 months
1
This item is relevant to you:
6 months - 1 year
3
This item is relevant to you:
1 - 2 years
2
This item is relevant to you:
2 - 5 years
7
This item is relevant to you:
5 - 10 years
5
This item is relevant to you:
10 years or more
3
Adherence
Adherence
Evaluations
Percentage
This item is relevant to you:
Always
24
24 evaluations from 19 patients
This item is relevant to you:
Usually
4
4 evaluations from 4 patients
This item is relevant to you:
Sometimes
1
1 evaluation from 1 patient
This item is relevant to you:
Never
taken as prescribed
2
2 evaluations from 2 patients
Burden
Burden
Evaluations
Percentage
This item is relevant to you:
Very
hard to take
6
6 evaluations from 6 patients
This item is relevant to you:
Somewhat
hard to take
3
3 evaluations from 3 patients
This item is relevant to you:
A little
hard to take
2
2 evaluations from 2 patients
This item is relevant to you:
Not at all
hard to take
20
20 evaluations from 14 patients
Cost per month
Cost per month
Evaluations
Percentage
This item is relevant to you:
$200+
0
0 evaluations from 0 patients
This item is relevant to you:
$100-199
0
0 evaluations from 0 patients
This item is relevant to you:
$50-99
1
1 evaluation from 1 patient
This item is relevant to you:
$25-49
1
1 evaluation from 1 patient
This item is relevant to you:
< $25
15
15 evaluations from 9 patients
This item is relevant to you:
Not specified
14
14 evaluations from 13 patients
What people switch to and from
Patients
stopped
taking
Nevirapine (NVP)
and
switched to:
Treatment
Patients
Percentage
This item is relevant to you:
Raltegravir (RAL)
(Isentress )
2
This item is relevant to you:
Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide
(Genvoya )
1
This item is relevant to you:
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil
(Stribild )
1
This item is relevant to you:
Darunavir (DRV)
(Prezista )
1
This item is relevant to you:
Efavirenz (EFV)
(Sustiva )
1
Show all
8 treatments
patients report switching to
Show top
5 treatments
patients report switching to
Last updated:
April 25, 2026